αCD2 mAb Treatment Safely Attenuates Adoptive Transfer Colitis
Laboratory Investigation - United Kingdom
doi 10.1038/labinvest.3700295
Full Text
Open PDFAbstract
Available in full text
Date
May 16, 2005
Authors
Publisher
Springer Science and Business Media LLC